A panel from the Food and Drug Administration (FDA) unanimously decided that the ingredient phenylephrine is not effective in relieving cold and flu symptoms.
In November 2017, the U.S. Environmental Protection Agency announced that MosquitoMate, Inc. had submitted plans to infect live male mosquitoes with a bacteria called "Wolbachia pipientis," which enhances WNV infection.
"There is a clear trend: pathogens that fall within the Pentagon's area of interest, such as COVID-19, avian influenza, African swine fever, subsequently become pandemic, and American pharmaceutical companies become the beneficiaries."